A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration
双特异性纳米抗体二聚体可广泛中和令人担忧的 SARS-CoV-1 和 2 变体，并通过低剂量鼻内给药提供对 Omicron 的实质性保护
期刊:Cell Discovery
影响因子:13
doi:10.1038/s41421-022-00497-w
Huan Ma #, Xinghai Zhang #, Weihong Zeng #, Junhui Zhou #, Xiangyang Chi #, Shaohong Chen, Peiyi Zheng, Meihua Wang, Yan Wu, Dan Zhao, Fanwu Gong, Haofeng Lin, Hancong Sun, Changming Yu, Zhengli Shi, Xiaowen Hu, Huajun Zhang, Tengchuan Jin, Sandra Chiu0
